NEW ROLES FOR FC RECEPTORS IN NEURODEGENERATION-THE IMPACT ON IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE

NEW ROLES FOR FC RECEPTORS IN NEURODEGENERATION-THE IMPACT ON IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE

There are an estimated 18 million Alzheimer’s disease (AD) sufferers worldwide and with no disease modifying treatment currently available, development of new therapies represents an enormous unmet clinical need. AD is characterised by episodic memory loss followed by severe cognitive decline and is...

Full description

Bibliographic Details
Main Authors: James P. Fuller, Jeffrey B. Stavenhagen, Jessica L. Teeling
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Neuroscience
Subjects:
Alzheimer Disease
Alzheimer Vaccines
Autoantibodies
Autoimmune Diseases
neurodegeneration
Neuroinflammation
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00235/full

Similar Items

Similar Items